Mouse models of arteriosclerosis: From arterial injuries to vascular grafts

American Journal of Pathology

Volumn 165, Issue 1, 2004, Pages 1-10

  Xu, Qingbo ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; ARTERIOSCLEROSIS; ARTERY INJURY; ATHEROSCLEROSIS; BLOOD VESSEL GRAFT; ENDOTHELIUM CELL; GENE MAPPING; INBRED STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER;

EID: 3042643632     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63270-1     Document Type: Review

References (75)

1. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull Jr W, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994, 89:2462-2478
2. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH: Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990, 15:1667-1687
3. Ignatowski AC: Influence of animal food on the organism of rabbits. Izvest Imper Voennomed Akad St Petersburg 1908, 16:154-173
4. Breslow JL: Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Proc Natl Acad Sci USA 1993, 90:8314-8318
5. Knowles JW, Maeda N: Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2000, 20:2336-2345
6. de Winther MP, Hofker MH: New mouse models for lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 2002, 13:191-197
7. Allayee H, Ghazalpour A, Lusis AJ: Using mice to dissect genetic factors in atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23:1501-1509
8. Levine GN, Chodos AP, Loscalzo J: Restenosis following coronary angioplasty: clinical presentations and therapeutic options. Clin Cardiol 1995, 18:693-703
9. Schwartz SM, deBlois D, O'Brien ER: The intima. Soil for atherosclerosis and restenosis. Circ Res 1995, 77:445-465
10. Clowes AW, Breslow JL, Karnovsky MJ: Regression of myointimal thickening following carotid endothelial injury and development of aortic foam cell lesions in long term hypercholesterolemic rats. Lab Invest 1977, 36:73-81
11. Lindner V, Fingerle J, Reidy MA: Mouse model of arterial injury. Circ Res 1993, 73:792-796
12. Kumar A, Lindner V: Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 1997, 17:2238-2244
13. Carmeliet P, Moons L, Stassen JM, De Mol M, Bouche A, van den Oord JJ, Kockx M, Collen D: Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am J Pathol 1997, 150:761-776
14. Leidenfrost JE, Khan MF, Boc KP, Villa BR, Collins ET, Parks WC, Abendschein DR, Choi ET: A model of primary atherosclerosis and post-angioplasty restenosis in mice. Am J Pathol 2003, 163:773-778
15. Wessely R, Hengst L, Jaschke B, Wegener F, Richter T, Lupetti R, Paschalidis M, Schomig A, Brandl R, Neumann FJ: A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia. Hum Mol Genet 2003, 12:177-187
16. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E: Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002, 91:852-859
17. Manka D, Collins RG, Ley K, Beaudet AL, Sarembock IJ: Absence of p-selectin, but not intercellular adhesion molecule-1, attenuates neointimal growth after arterial injury in apolipoprotein E-deficient mice. Circulation 2001, 103:1000-1005
18. Schober A, Manka D, von Hundelshausen P, Huo Y, Hanrath P, Sarembock IJ, Ley K, Weber C: Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation 2002, 106:1523-1529
19. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken AH: Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury. Am J Physiol 2002, 283:R505-R512
20. Gimbrone Jr MA, Resnick N, Nagel T, Khachigian LM, Collins T, Topper JN: Hemodynamics, endothelial gene expression, and atherogenesis. Ann NY Acad Sci 1997, 811:1-11
21. Xu Q: Biomechanical-stress-induced signaling and gene expression in the development of arteriosclerosis. Trends Cardiovasc Med 2000, 10:35-41
22. Li C, Xu Q: Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 2000, 12:435-445
23. Guyton JR, Hartley CJ: Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter. Am J Physiol 1985, 248: H540-H546
24. Langille BL, O'Donnell F: Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986, 231:405-407
25. Ku DN, Giddens DP, Zarins CK, Glagov S: Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 1985, 5:293-302
26. Booth RF, Martin JF, Honey AC, Hassall DG, Beesley JE, Moncada S: Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989, 76:257-268
27. Moroi M, Zhang L, Yasuda T, Virmani R, Gold HK, Fishman MC, Huang PL: Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest 1998, 101:1225-1232
28. Davies MG, Hagen PO: Pathobiology of intimal hyperplasia. Br J Surg 1994, 81:1254-1269
29. Mehta D, Izzat MB, Bryan AJ, Angelini GD: Towards the prevention of vein graft failure. Int J Cardiol 1997, 62(Suppl 1):S55-S63
30. Zou Y, Dietrich H, Hu Y, Metzler B, Wick G, Xu Q: Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998, 153:1301-1310
31. Mayr M, Li C, Zou Y, Huemer U, Hu Y, Xu Q: Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 2000, 14:261-270
32. Dietrich H, Hu Y, Zou Y, Huemer U, Metzler B, Li C, Mayr M, Xu Q: Rapid development of vein graft atheroma in ApoE-deficient mice. Am J Pathol 2000, 157:659-669
33. Lardenoye JH, de Vries MR, Lowik CW, Xu Q, Dhore CR, Cleutjens JP, van Hinsbergh VW, van Bockel JH, Quax PH: Accelerated atherosclerosis and calcification in vein grafts: a study in APOE*3 Leiden transgenic mice. Circ Res 2002, 91:577-584
34. Mayr U, Mayr M, Li C, Wernig F, Dietrich H, Hu Y, Xu Q: Loss of p53 accelerates neointimal lesions of vein bypass grafts in mice. Circ Res 2002, 90:197-204
35. Mayr M, Hu Y, Hainaut H, Xu Q: Mechanical stress-induced DNA damage and rac-p38MAPK signal pathways mediate p53-dependent apoptosis in vascular smooth muscle cells. FASEB J 2002, 16:1423-1425
36. Wernig F, Xu Q: Mechanical stress-induced apoptosis in cardiovascular system. Prog Biophys Mol Biol 2002, 78:105-137
37. Wernig F, Mayr M, Xu Q: Mechanical stretch-induced apoptosis in smooth muscle cells is mediated by beta1-integrin signaling pathways. Hypertension 2003, 41:903-911
38. Lardenoye JH, De Vries MR, Grimbergen JM, Havekes LM, Knaapen MW, Kockx MM, van Hinsbergh VW, van Bockel JH, Quax PH: Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice. Arterioscler Thromb Vasc Biol 2002, 22:1433-1438
39. Hu Y, Zou Y, Dietrich H, Wick G, Xu Q: Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin. Circulation 1999, 100:861-868
40. Hu Y, Baker AH, Zou Y, Newby AC, Xu Q: Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model. Arterioscler Thromb Vasc Biol 2001, 21:1275-1280
41. Ross R: The pathogenesis of atherosclerosis-an update. N Engl J Med 1986, 314:488-500
42. Xu Q, Zhang Z, Davison F, Hu Y: Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in apoE-deficient mice. Circ Res 2003, 93:e76-e86
43. Hu Y, Mayr M, Metzler B, Erdel M, Davison F, Xu Q: Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res 2002, 91:e13-e20
44. Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT: Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987, 76:827-834
45. Weis M, von Scheidt W: Cardiac allograft vasculopathy: a review. Circulation 1997, 96:2069-2077
46. Libby P, Pober JS: Chronic rejection. Immunity 2001, 14:387-397
47. Shi C, Russell ME, Bianchi C, Newell JB, Haber E: Murine model of accelerated transplant arteriosclerosis. Circ Res 1994, 75:199-207
48. Koulack J, McAlister VC, Giacomantonio CA, Bitter-Suermann H, MacDonald AS, Lee TD: Development of a mouse aortic transplant model of chronic rejection. Microsurgery 1995, 16:110-113
49. Dietrich H, Hu Y, Zou Y, Dirnhofer S, Kleindienst R, Wick G, Xu Q: Mouse model of transplant arteriosclerosis: role of intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol 2000, 20:343-352
50. Koulack J, McAlister VC, MacAulay MA, Bitter-Suermann H, MacDonald AS, Lee TD: Importance of minor histocompatibility antigens in the development of allograft arteriosclerosis. Clin Immunol Immunopathol 1996, 80:273-277
51. Shi C, Lee WS, He Q, Zhang D, Fletcher Jr DL, Newell JB, Haber E: Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci USA 1996, 93:4051-4056
52. Sun H, Subbotin V, Chen C, Aitouche A, Valdivia LA, Sayegh MH, Linsley PS, Fung JJ, Starzl TE, Rao AS: Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997, 64:1838-1843
53. Moons L, Shi C, Ploplis V, Plow E, Haber E, Collen D, Carmeliet P: Reduced transplant arteriosclerosis in plasminogen-deficient mice. J Clin Invest 1998, 102:1788-1797
54. Shi C, Feinberg MW, Zhang D, Patel A, Sim CU, Dong ZM, Chapman SM, Gutierrez-Ramos JC, Wagner DD, Sibinga NE, Haber E: Donor MHC and adhesion molecules in transplant arteriosclerosis. J Clin Invest 1999, 103:469-474
55. Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN: Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol 1999, 155:1929-1939
56. Nagano H, Mitchell RN, Taylor MK, Hasegawa S, Tilney NL, Libby P: Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997, 100:550-557
57. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS: Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000, 403:207-211
58. Lee JK, Borhani M, Ennis TL, Upchurch Jr GR, Thompson RW: Experimental abdominal aortic aneurysms in mice lacking expression of inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2001, 21:1393-1401
59. Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983, 158:670-689
60. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS: Wide-spread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med 1985, 162:1645-1664
61. Shears LL, Kawaharada N, Tzeng E, Billiar TR, Watkins SC, Kovesdi I, Lizonova A, Pham SM: Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest 1997, 100:2035-2042
62. Lee PC, Wang ZL, Qian S, Watkins SC, Lizonova A, Kovesdi I, Tzeng E, Simmons RL, Billiar TR, Shears II LL: Endothelial nitric oxide synthase protects aortic allografts from the development of transplant arteriosclerosis. Transplantation 2000, 69:1186-1192
63. Kennedy Jr LJ, Weissman IL: Dual origin of intimal cells in cardiac-allograft arteriosclerosis. N Engl J Med 1971, 285:884-887
64. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN: Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001, 7:738-741
65. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R: Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409
66. Li J, Han X, Jiang J, Zhong R, Williams GM, Pickering JG, Chow LH: Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am J Pathol 2001, 158:1943-1947
67. Hu Y, Davison F, Ludewig B, Erdel M, Mayr M, Url M, Dietrich H, Xu Q: Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002, 106:1834-1839
68. Moessler H, Mericskay M, Li Z, Nagl S, Paulin D, Small JV: The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 1996, 122:2415-2425
69. Ludewig B, Freigang S, Jaggi M, Kurrer MO, Pei YC, Vlk L, Odermatt B, Zinkernagel RM, Hengartner H: Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc Natl Acad Sci USA 2000, 97:12752-12757
70. Hu Y, Davison F, Zhang ZG, Xu Q: Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 2003, 108:3122-3127
71. Glaser R, Lu MM, Narula N, Epstein JA: Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 2002, 106:17-19
72. Metzler B, Mair J, Lercher A, Schaber C, Hintringer F, Pachinger O, Xu Q: Mouse model of myocardial remodelling after ischemia: role of intercellular adhesion molecule-1. Cardiovasc Res 2001, 49:399-407
73. Zou Y, Hu Y, Mayr M, Dietrich H, Wick G, Xu Q: Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ Res 2000, 86:434-440
74. Kuhel DG, Zhu B, Witte DP, Hui DY: Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice. Arterioscler Thromb Vasc Biol 2002, 22:955-960
75. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA: Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987, 68:231-240